MFSD2A and Alzheimer disease: This upregulation of Mfsd2a was accompanied by reduced amyloid β (Aβ) deposition in retinal vasculature and normalization of Aqp4, a glymphatic system marker that was elevated in AD models, indicative of glymphatic dysfunction.